Ghent University Academic Bibliography

Advanced

Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs.

G VERBRUGGEN, S GOEMAERE and Eric Veys (2002) CLINICAL RHEUMATOLOGY. 21(3). p.231-243
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
CLINICAL RHEUMATOLOGY
Clin. Rheumatol.
volume
21
issue
3
pages
231-243 pages
Web of Science type
Article
Web of Science id
000177090700010
JCR category
RHEUMATOLOGY
JCR impact factor
0.976 (2002)
JCR rank
15/22 (2002)
JCR quartile
3 (2002)
ISSN
0770-3198
language
English
UGent publication?
yes
classification
A1
id
165216
handle
http://hdl.handle.net/1854/LU-165216
date created
2004-01-14 13:40:00
date last changed
2016-12-19 15:38:57
@article{165216,
  author       = {VERBRUGGEN, G and GOEMAERE, S and Veys, Eric},
  issn         = {0770-3198},
  journal      = {CLINICAL RHEUMATOLOGY},
  language     = {eng},
  number       = {3},
  pages        = {231--243},
  title        = {Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs.},
  volume       = {21},
  year         = {2002},
}

Chicago
VERBRUGGEN, G, S GOEMAERE, and Eric Veys. 2002. “Systems to Assess the Progression of Finger Joint Osteoarthritis and the Effects of Disease Modifying Osteoarthritis Drugs.” Clinical Rheumatology 21 (3): 231–243.
APA
VERBRUGGEN, G., GOEMAERE, S., & Veys, E. (2002). Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. CLINICAL RHEUMATOLOGY, 21(3), 231–243.
Vancouver
1.
VERBRUGGEN G, GOEMAERE S, Veys E. Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. CLINICAL RHEUMATOLOGY. 2002;21(3):231–43.
MLA
VERBRUGGEN, G, S GOEMAERE, and Eric Veys. “Systems to Assess the Progression of Finger Joint Osteoarthritis and the Effects of Disease Modifying Osteoarthritis Drugs.” CLINICAL RHEUMATOLOGY 21.3 (2002): 231–243. Print.